Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
Clin Res Hepatol Gastroenterol
    March 2024
  1. YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
    The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102317.
    >> Share

    December 2023
  2. GRELLIER N, Sokol H, Seksik P
    Gut dysbiosis in Crohn's disease: never so close to solving the chicken-and-egg enigma: Commentary to "Gut Microbiome Composition Is Associated with Future Onset of Crohn's Disease in Healthy First-Degree Relatives, by Raygoza Garay JA et al., Gastroe
    Clin Res Hepatol Gastroenterol. 2023 Dec 23:102272.
    >> Share

    November 2023
  3. KAKDIYA R, Jha DK, Choudhury A, Jena A, et al
    Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023 Nov 23:102250.
    >> Share

  4. UZZAN M, Assouline V, Chambenois E, Djabbari M, et al
    Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Nov 13:102246.
    >> Share

    September 2023
  5. ZHANG C, Liu X
    Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102214.
    >> Share

    June 2023
  6. JENA A, Neelam PB, Telaprolu H, Mangipudi UK, et al
    Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.
    Clin Res Hepatol Gastroenterol. 2023 Jun 8:102155.
    >> Share

    April 2023
  7. DAR SH, Maniya MT, Merza N, Musheer A, et al
    The Association of Antibiotic Exposure with New-Onset Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Clin Res Hepatol Gastroenterol. 2023 Apr 26:102129.
    >> Share

    March 2023
  8. DE PARADES V, Fathallah N, Peyrin-Biroulet L
    The case for the prevention of fistulas in patients with perianal Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Mar 21:102113.
    >> Share

  9. BOZON A, Nancey S, Serrero M, Caillo L, et al
    Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under biologics: A Prospective, Multicenter, Observational, One-Year follow-up comparative study.
    Clin Res Hepatol Gastroenterol. 2023 Mar 9:102107.
    >> Share

    February 2023
  10. ZHANG L, Hu C, Zhang Z, Liu R, et al
    Association Between Prior Appendectomy and The Risk and Course of Crohn's Disease: A Systematic Review and Meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023 Feb 4:102090.
    >> Share

    January 2023
  11. CHEN LT, Zhang JY, Zheng JW, Yu J, et al
    The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102076.
    >> Share

    November 2022
  12. PENG C, Zheng C, Xie Y, Sun Q, et al
    Granulomatosis with Polyangiitis with colon involvement as a mimicker of Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;47:102057.
    >> Share

  13. FAVAREL-GARRIGUES M, Cadiot G, Bermejo M, Boulagnon-Rombi C, et al
    Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101989.
    >> Share

  14. RABILLOUD ML, Bajeux E, Siproudhis L, Hamonic S, et al
    Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997.
    Clin Res Hepatol Gastroenterol. 2022;46:101974.
    >> Share

    October 2022
  15. GONZALEZ-MORCILLO G, Calderon-Hernanz B, Serrano-Lopez de Las Hazas J, de Hita-Santabaya AI, et al
    Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2022;46:101956.
    >> Share

  16. VEISMAN I, Lederer NB, Ukashi O, Kopylov U, et al
    Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101959.
    >> Share

    August 2022
  17. GOETGEBUER RL, Masclee GMC, van der Eijk AA, van der Woude CJ, et al
    Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report.
    Clin Res Hepatol Gastroenterol. 2022;46:101948.
    >> Share

    June 2022
  18. NAYAGAM JS, Mandour MO, Taylor A, Heneghan MA, et al
    Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022 Jun 18:101980.
    >> Share

    April 2022
  19. YZET C, Brazier F, Sebbagh V, Vanelslander P, et al
    Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study.
    Clin Res Hepatol Gastroenterol. 2022;46:101887.
    >> Share

  20. HE C, Li H, Zhou P, Zhang W, et al
    A novel XIAP mutation in an adult Chinese patient with refractory Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101845.
    >> Share

    February 2022
  21. XIA H, Li S, He Y, Ren Q, et al
    Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2022 Feb 25:101895.
    >> Share

    January 2022
  22. CHAZOUILLERES O, Potier P, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101775.
    >> Share

    September 2021
  23. FUENTES-VALENZUELA E, Navarro Canadas C, Oyarzun Bahamonde E, Moreta Rodriguez M, et al
    Severe sarcoidosis-like reaction in a patient with Crohn's Disease treated with infliximab. Any relationship?
    Clin Res Hepatol Gastroenterol. 2021;45:101696.
    >> Share

  24. TILMANT M, Serrero M, Poullenot F, Bouguen G, et al
    Endoscopic balloon dilation of colorectal strictures complicating Crohn's disease: a multicenter study.
    Clin Res Hepatol Gastroenterol. 2021;45:101561.
    >> Share

  25. RIAULT C, Diouf M, Chatelain D, Yzet C, et al
    Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101569.
    >> Share

  26. TER AVEST MM, van Hee K, Bronkhorst C, de Jonge HJM, et al
    Mesalazine induced autoimmune hepatitis in a patient with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101551.
    >> Share

    July 2021
  27. LUCOTTI P, Lovati E, Lenti MV, Valvo B, et al
    Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101533.
    >> Share

    March 2021
  28. TEMTEM T, Whitworth J, Zhang J, Bagga B, et al
    Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101625.
    >> Share

  29. BUFFET-BATAILLON S, Landreau C, Siproudhis L, Cattoir V, et al
    Bacterial gut dysbiosis is associated with Crohn's disease symptoms but not with elevated fecal calprotectin.
    Clin Res Hepatol Gastroenterol. 2021;45:101669.
    >> Share

    October 2020
  30. MASNADI SHIRAZI K, Sotoudeh S, Masnadi Shirazi A, Moaddab SY, et al
    Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial.
    Clin Res Hepatol Gastroenterol. 2020 Oct 14. pii: S2210-7401(20)30270.
    >> Share

  31. WANG HG, Xie R, Ma TH, Yang XZ, et al
    Excessive anxiety in IBD patients is unnecessary for COVID-19.
    Clin Res Hepatol Gastroenterol. 2020;44:e121-e122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016